An ambitious new AI model called GET (General Expression Transformer) promises to rewrite the rulebook for transcriptional regulation, a cornerstone of biological processes. Unveiled by researchers from MBZUAI, Columbia University and Carnegie Mellon, GET is not just another computational biology tool—it’s a leap forward in the form of a foundational model designed to predict gene expression across 213 human cell types. Learn more at https://www.computerspeak.co/p/get-is-a-new-model-for-understanding-biology 

Also in the news this week: 

[*] The Atlantic: A Virtual Cell Is a ‘Holy Grail’ of Science. It’s Getting Closer.

[*] Time: How China Is Advancing in AI Despite U.S. Chip Restrictions

[*] Wired: AI Social Media Users Are Not Always a Totally Dumb Idea

[*] Reuters: AI startups drive VC funding resurgence, capturing record US investment in 2024

[*] FT: Healthcare turns to AI for medical note-taking ‘scribes’

[*] WSJ: How Are Companies Using AI Agents? Here’s a Look at Five Early Users of the Bots

[*] CNBC: How AI regulation could shake out in 2025

[*] Bloomberg: Sam Altman on ChatGPT’s First Two Years, Elon Musk and AI Under Trump

[*] TechCrunch: Google is forming a new team to build AI that can simulate the physical world

[*] MIT Technology Review: AI means the end of internet search as we’ve known it

[*] Business Insider: A VC firm created an AI agent-powered 'investment memo generator.' It's the latest example of how AI is coming for venture firms.